BioSurf Hard Surface Disinfectant -710 ml

BioSURF Hard Surface Disinfectant 

Hospital-level hard surface disinfectant. Available in 750ml trigger spray and 5 Litre Box

Category: SKU: RM_LIQ_01 Tag:


Micrylium BioSURF Hard Surface Disinfectant 710ml and 5 Litre

BioSURF is the world’s fastest one step surface disinfectant. Unlike most disinfectants that can take up to 10 minutes to disinfect, BioSURF works within seconds. Despite the impressive performance, BioSURF is designed to not harm people or the environment. BioSURF is the perfect choice for rapid disinfection of counters, trays, metal instruments and other surfaces.

  • Works in dirty conditions
  • Compatible with silicone, alginate and polyvinylsiloxane
  • Designed to remove proteins, inks, dyes, lipids, waxes and oils

Protocol: Remove trigger from BioSURF Spray Bottle and pour BioSURF using a clean funnel into the bottle from 500mL refill pouch or 5 litre Bag-in-Box spigot. Replace trigger and rinse funnel.
Spray BioSURF lightly as a mist over surfaces to be disinfected. Wait one minute then wipe thoroughly with disposable paper towels.

Helpful Hints: USE FULL STRENGTH – Never dilute. AVOID CONCURRENT USE WITH BLEACH as staining (yellow/brown) can occur. On white uniforms this can be removed by soaking in Borax.
ALWAYS WIPE – BioSURF contains detergents that may be slippery or build up. CAUTION – NOT FOR USE on acrylic latex painted surfaces or vinyl upholstery. Avoid longer than 10 minutes contact time with rubber or latex materials.

BioSURF will NOT corrode metals, stain or become tacky as do water-based chlorine, Chlorhexidine or iodine products.

BioSURF contains NO phenols or aldehydes. It does NOT contain noted hormone disrupting chemicals or nonyl-phenyl ethoxylate-based surfactants.

[pdf-embedder url=”” title=”2017 Protocol SURF (1)”]

All disinfectants that have a drug identification number (DIN) have been approved for sale in Canada. While most disinfectants will work against coronavirus, the following list of hard-surface disinfectants are supported by evidence following drug review, demonstrating that they are likely to be effective and may be used against SARS-CoV-2, the coronavirus that causes COVID-19.